Hester Biosciences, an Indo-American joint venture company, manufacturing poultry vaccines in India  on Thursday said the company's revenues have not been impacted in this current Bird Flu situation prevailing in India.

"We continue to grow as per our forecasted growth plans," the company added.

There have been Bird Flu outbreaks across India. The spread of Bird Flu has been mainly through migratory wild birds.

In the winter months, wild birds migrate to the tropical areas, India being in the tropics. These birds may have been infected with Bird Flu. They carry the disease along their travel path and infect other birds in the journey.

No country has control over the movements of the migratory wild birds or on their spreading of any disease including Bird Flu disease. These migratory wild birds first infect other wild birds in those geographies which then locally spread the disease. Bird Flu could then spread in organized poultry as well as backyard poultry, it said.

The Indian Government's policy towards controlling Bird Flu in poultry is by stamping out the infected poultry population. While there have been Bird Flu outbreaks in organized poultries in India, Hester's technical team has been assisting the poultry industry by improving the biosecurity and general health condition of poultry to ward off the disease, the company said.

Shares of the company gained Rs 24.70, or 1.41%, to trade at  Rs 1,695.80  The total volume of shares traded  was 487,899 at the BSE (10:50 a.m, Thursday).